Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
about
Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targetsRepurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentThe Repurposing Drugs in Oncology (ReDO) Project.Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentRepurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentNext generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.The effects of selected drugs and dietary compounds on proliferation and apoptosis in colorectal carcinoma.Histamine H₄ receptors in the gastrointestinal tract.Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentMicrovessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.
P2860
Q28541360-1EFAC0FD-6672-4347-901A-1CB3E70F2ECDQ33893928-C6B67E8A-F2B3-4618-92E4-F6EB167B2920Q33893949-101A4640-EFA6-4FF9-BA03-1E396EC9A2FEQ34474583-333FFADF-7880-4DCA-8FCD-800CE151A61FQ36483712-19C59F96-1E6E-4A60-81D5-F914BBC63094Q37404693-5FE140A9-839E-498A-8337-ACB18038E048Q37458763-35A88697-25FC-4108-814B-5B1400E7398DQ38156480-B217B69D-90E0-4861-A3F2-4AAAD7C608F7Q38254576-0133AF04-71B0-4CD1-AA25-A20C2CBE5146Q38264340-E5FE68F1-C2C8-4A92-8C06-06D76BCD318EQ40468319-707FD0ED-95C9-4761-B40C-B8F62F6B6F2AQ41668110-1A4D008C-A550-4ED0-9A8F-0DCD4D9A815FQ51810088-82872738-9F7F-4FB7-8F9E-E627F94B227FQ55247585-9F31BF70-30AC-4926-A0F5-68E26387C2D5
P2860
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Histamine type 2 receptor anta ...... for resected colorectal cancer
@ast
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en-gb
Histamine type 2 receptor anta ...... for resected colorectal cancer
@nl
type
label
Histamine type 2 receptor anta ...... for resected colorectal cancer
@ast
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en-gb
Histamine type 2 receptor anta ...... for resected colorectal cancer
@nl
prefLabel
Histamine type 2 receptor anta ...... for resected colorectal cancer
@ast
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en-gb
Histamine type 2 receptor anta ...... for resected colorectal cancer
@nl
P2860
P3181
P1476
Histamine type 2 receptor anta ...... for resected colorectal cancer
@en
P2093
Michael Jameson
Sanjeev Deva
P2860
P3181
P356
10.1002/14651858.CD007814.PUB2
P577
2012-08-15T00:00:00Z